ArticleTherapeutic advances in drug safety2016

Cardiovascular risk with DPP-4 inhibitors: latest evidence and clinical implications.

Thomas Karagiannis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.